Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report

Since nucleoside-modified mRNA vaccines strongly activate T follicular helper cells, it is important to explore the possible impact of approved SARS-CoV-2 mRNA vaccines on neoplasms affecting this cell type. Herein, we report and discuss unexpected rapid progression of lymphomatous lesions after adm...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldman, Serge, Bron, Dominique, Tousseyn, Thomas, Vierasu, Irina, Dewispelaere, Laurent, Heimann, Pierre, Cogan, Elie, Goldman, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656165/
https://www.ncbi.nlm.nih.gov/pubmed/34901098
http://dx.doi.org/10.3389/fmed.2021.798095
_version_ 1784612227780706304
author Goldman, Serge
Bron, Dominique
Tousseyn, Thomas
Vierasu, Irina
Dewispelaere, Laurent
Heimann, Pierre
Cogan, Elie
Goldman, Michel
author_facet Goldman, Serge
Bron, Dominique
Tousseyn, Thomas
Vierasu, Irina
Dewispelaere, Laurent
Heimann, Pierre
Cogan, Elie
Goldman, Michel
author_sort Goldman, Serge
collection PubMed
description Since nucleoside-modified mRNA vaccines strongly activate T follicular helper cells, it is important to explore the possible impact of approved SARS-CoV-2 mRNA vaccines on neoplasms affecting this cell type. Herein, we report and discuss unexpected rapid progression of lymphomatous lesions after administration of a BNT162b2 mRNA vaccine booster in a man recently diagnosed with AITL.
format Online
Article
Text
id pubmed-8656165
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86561652021-12-10 Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report Goldman, Serge Bron, Dominique Tousseyn, Thomas Vierasu, Irina Dewispelaere, Laurent Heimann, Pierre Cogan, Elie Goldman, Michel Front Med (Lausanne) Medicine Since nucleoside-modified mRNA vaccines strongly activate T follicular helper cells, it is important to explore the possible impact of approved SARS-CoV-2 mRNA vaccines on neoplasms affecting this cell type. Herein, we report and discuss unexpected rapid progression of lymphomatous lesions after administration of a BNT162b2 mRNA vaccine booster in a man recently diagnosed with AITL. Frontiers Media S.A. 2021-11-25 /pmc/articles/PMC8656165/ /pubmed/34901098 http://dx.doi.org/10.3389/fmed.2021.798095 Text en Copyright © 2021 Goldman, Bron, Tousseyn, Vierasu, Dewispelaere, Heimann, Cogan and Goldman. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Goldman, Serge
Bron, Dominique
Tousseyn, Thomas
Vierasu, Irina
Dewispelaere, Laurent
Heimann, Pierre
Cogan, Elie
Goldman, Michel
Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report
title Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report
title_full Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report
title_fullStr Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report
title_full_unstemmed Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report
title_short Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report
title_sort rapid progression of angioimmunoblastic t cell lymphoma following bnt162b2 mrna vaccine booster shot: a case report
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656165/
https://www.ncbi.nlm.nih.gov/pubmed/34901098
http://dx.doi.org/10.3389/fmed.2021.798095
work_keys_str_mv AT goldmanserge rapidprogressionofangioimmunoblastictcelllymphomafollowingbnt162b2mrnavaccineboostershotacasereport
AT brondominique rapidprogressionofangioimmunoblastictcelllymphomafollowingbnt162b2mrnavaccineboostershotacasereport
AT tousseynthomas rapidprogressionofangioimmunoblastictcelllymphomafollowingbnt162b2mrnavaccineboostershotacasereport
AT vierasuirina rapidprogressionofangioimmunoblastictcelllymphomafollowingbnt162b2mrnavaccineboostershotacasereport
AT dewispelaerelaurent rapidprogressionofangioimmunoblastictcelllymphomafollowingbnt162b2mrnavaccineboostershotacasereport
AT heimannpierre rapidprogressionofangioimmunoblastictcelllymphomafollowingbnt162b2mrnavaccineboostershotacasereport
AT coganelie rapidprogressionofangioimmunoblastictcelllymphomafollowingbnt162b2mrnavaccineboostershotacasereport
AT goldmanmichel rapidprogressionofangioimmunoblastictcelllymphomafollowingbnt162b2mrnavaccineboostershotacasereport

Ejemplares similares